Ligustrum × vicaryi Fruit Polysaccharide Attenuates LPS/D-GalN-Induced Acute Liver Injury in Mice
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27198805 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Shu-Ling Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jining Medical University, Rizhao 276826, China. Hauptthemen laut MEDLINE: Ligustrum, Polysaccharides, Lipopolysaccharides, Chemical and Drug Induced Liver Injury. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Fund for Academician Lin He, Research Fund for Academician Lin He New Medicine.
Abstract (Originalsprache)
The dried fruits of Ligustrum lucidum Ait. are well-established in East Asian medicine for hepatoprotection. Given this ethnopharmacological precedent and their close taxonomic kinship, we hypothesized that the fruit polysaccharide of its horticultural congener, Ligustrum × vicaryi L. (LVFP), may confer analogous hepatic benefits. We assessed LVFP in a murine model of acute liver injury (ALI) induced by lipopolysaccharide and D-galactosamine (LPS/D-GalN) to test this hypothesis. LVFP pretreatment significantly mitigated hepatic pathological damage, normalized serum aminotransferases (AST, ALT), and reversed lipid peroxidation (reduced MDA, elevated SOD). Simultaneously, LVFP reduced pro-inflammatory cytokines, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), and corrected lipid metabolic abnormalities (CHO, TG). To decode these phenotypic rescues, network pharmacology and molecular docking nominated a 10-gene hub signature (featuring KDR (binding energy = −8.65 kcal/mol), AKT1, GSK3B, and IL2). we further found that this signature—particularly KDR and PKM—robustly discriminates ALI from controls (AUC = 1.00; AUPR = 0.848), supporting its disease relevance. Collectively, these findings support our initial hypothesis that LVFP exerts multi-dimensional hepatoprotection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Jining Medical University, Rizhao 276826, China.
- Institute of Immunology and Molecular Medicine, Jining Key Laboratory of Immunology, Jining Medical University, Jining 272067, China.
ORCID-Profile: Shu-Ling Liu, Hui Zhang, Li-Tao Wang
Förderung
- Research Fund for Academician Lin He
- Research Fund for Academician Lin He New Medicine
Zitieren
APA
Liu, S. L., Zhang, H., Wang, J. A., Lv, R. D., Li, S. J., & Wang, L. T. (2026). Ligustrum × vicaryi Fruit Polysaccharide Attenuates LPS/D-GalN-Induced Acute Liver Injury in Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198805
Vancouver
Liu SL, Zhang H, Wang JA, Lv RD, Li SJ, Wang LT. Ligustrum × vicaryi Fruit Polysaccharide Attenuates LPS/D-GalN-Induced Acute Liver Injury in Mice. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198805
BibTeX
@article{Liu2026,
author = {Liu, Shu-Ling and Zhang, Hui and Wang, Jian-An and Lv, Run-Dong and Li, Shao-Jian and Wang, Li-Tao},
title = {Ligustrum × vicaryi Fruit Polysaccharide Attenuates LPS/D-GalN-Induced Acute Liver Injury in Mice},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27198805}
}
EUVIMED